$16.17
0.23[1.44%]
At close: Apr 26
$16.17
0[0.00%]
After Hours: 4:20PM EDT
Edgewise Therapeutics: Insider buying and selling updated today.
Filing Date | Insider Names | Insider Title | Qty. | Price | Size ($) | Type | Δ Own | Own | Trade Dates | SEC Filing |
---|---|---|---|---|---|---|---|---|---|---|
Feb 09, 2024 | John R Moore | GENERAL COUNSEL | 0 | $10.97 | -$539.22K | SELL-OPTIONS | 0.00% | 0 | Feb 07 - Feb 09 | View |
Feb 09, 2024 | Behrad Derakhshan | CHIEF BUSINESS OFFICER | 0 | $10.98 | -$180.96K | SELL-OPTIONS | 0.00% | 7.02K | Feb 07 - Feb 09 | View |
Jan 25, 2024 | R. Michael Carruthers | CHIEF FINANCIAL OFFICER | 0 | $8.85 | -$1.25M | SELL-OPTIONS | 0.00% | 29.024K | Jan 23 | View |
Jan 25, 2024 | Peter A Thompson | DIRECTOR | 454.545K | $11.00 | $5.00M | BUY | 3.18% | 14.756096M | Jan 23 | View |
Jan 25, 2024 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLC | DIRECTOR | 454.545K | $11.00 | $5.00M | BUY | 3.18% | 14.756096M | Jan 23 | View |
Dec 28, 2023 | Fox Jonathan C | 10.857K | $9.30 | $100.96K | BUY | ∞ | 10.857K | Dec 26 | View | |
Dec 28, 2023 | John R Moore | GENERAL COUNSEL | -8.497K | $10.50 | -$89.22K | SELL | -100.00% | 0 | Dec 27 | View |
Dec 28, 2023 | Russell Alan J | CHIEF SCIENTIFIC OFFICER | -172.585K | $9.33 | -$1.61M | SELL | -97.95% | 3.606K | Dec 26 | View |
May 03, 2023 | Behrad Derakhshan | CHIEF BUSINESS OFFICER | 3.461K | $8.90 | -$15.56K | SELL-OPTIONS | 97.25% | 7.02K | May 01 - May 02 | View |
May 03, 2023 | John R Moore | GENERAL COUNSEL | 3.311K | $8.90 | -$16.89K | SELL-OPTIONS | 101.75% | 6.565K | May 01 - May 02 | View |
May 03, 2023 | R. Michael Carruthers | CHIEF FINANCIAL OFFICER | 3.872K | $8.90 | -$11.90K | SELL-OPTIONS | 31.60% | 16.126K | May 01 - May 02 | View |
May 03, 2023 | Russell Alan J | CHIEF SCIENTIFIC OFFICER | 3.606K | $8.90 | -$14.27K | SELL-OPTIONS | 2.09% | 176.191K | May 01 - May 02 | View |
May 03, 2023 | Donovan Joanne M | CMO | 7.162K | $8.90 | -$28.98K | SELL-OPTIONS | 255.97% | 9.96K | May 01 - May 02 | View |
May 03, 2023 | Kevin Koch | PRESIDENT AND CEO | 7.213K | $8.90 | -$28.52K | SELL-OPTIONS | 27.31% | 33.623K | May 01 - May 02 | View |
Oct 05, 2022 | John R Moore | GENERAL COUNSEL | 0 | $5.84 | -$37.03K | SELL-OPTIONS | 0.00% | 3K | Oct 03 | View |
Sep 16, 2022 | Peter A Thompson | DIRECTOR | 484.496K | $10.32 | $5.00M | BUY | 3.51% | 14.301551M | Sep 16 | View |
Sep 16, 2022 | ORBIMED ADVISORS LLCOrbiMed Capital GP VI LLCOrbiMed Genesis GP LLC | DIRECTOR | 484.496K | $10.32 | $5.00M | BUY | 3.51% | 14.301551M | Sep 16 | View |
Sep 16, 2022 | Novo Holdings AS | 10% OWNER | 484.496K | $10.32 | $5.00M | BUY | 8.67% | 6.071703M | Sep 14 | View |
Sep 08, 2022 | John R Moore | GENERAL COUNSEL | 0 | $6.42 | -$42.47K | SELL-OPTIONS | 0.00% | 3K | Sep 06 | View |
Browse insider trades on all stocks.